DiaSorin Molecular recently released an updated version of its Simplexa Variants Direct assay to detect mutations associated with the new omicron variant of SARS-CoV-2.
The assay helps with preselection of positive samples that would benefit from further sequencing which in turn helps with monitoring programs for the spread of concerning variants.
The assay is for research use only and is not for use in diagnostics procedures. It works directly on nasopharyngeal and nasal swab specimens that were identified as positive for SARS-CoV-2. It also allows for in vitro qualitative detection of the mut
